Premium
CD40 Is Required for Development of Islet Inflammation in the RIP‐CD154 Transgenic Mouse Model of Type 1 Diabetes
Author(s) -
HAASE CLAUS,
MARKHOLST HELLE
Publication year - 2007
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1381.039
Subject(s) - insulitis , cd154 , cd40 , inflammation , immune system , islet , transgene , bone marrow , immunology , biology , genetically modified mouse , autoimmunity , diabetes mellitus , endocrinology , gene , cytotoxic t cell , genetics , in vitro
Type 1 diabetes is believed to be an autoimmune disease where cells of the immune system destroy the insulin‐producing β cells in the islets of Langerhans. The trigger(s) of the inflammatory reaction is yet unknown, but both genetic and environmental factors, including viruses or other pathogens, are thought to play a role. We have recently described a transgenic mouse model—the RIP‐CD154 mouse—in which β‐cell–specific expression of CD154 (CD40 ligand) mediates immune activation, insulitis, and diabetes on a non–diabetes‐prone background. By the use of bone marrow chimeric mice, we now demonstrate that a functional Cd40 gene is necessary for islet inflammation and we show that CD40 expression on bone marrow–derived cells is sufficient to trigger activation of the immune system and development of insulitis.